Pulmonary hypertension deaths have increased over past decade, according to CDC report

April 3, 2014, American College of Chest Physicians

Deaths from pulmonary hypertension have increased over the past decade, according to a study from the Centers for Disease Control and Prevention (CDC).

In the study, published online in CHEST, researchers analyzed death rates from the National Vital Statistics System and data from the National Hospital Discharge Survey between 2001 and 2010 to analyze trends in hospitalizations and death rates related to pulmonary hypertension.

Pulmonary hypertension is characterized by increased blood pressure in the , causing the right side of the heart to work harder. Common causes of pulmonary hypertension include , other heart diseases, birth defects of the heart, , , and certain autoimmune disease such as rheumatoid arthritis. The risk of pulmonary hypertension increases in older patients.

"With expanding research into the diagnosis and treatment of pulmonary hypertension, it is important to provide updated statistics on this disease's impact on hospitalization and death rates," says Mary George, MD, researcher with the Division for Heart Disease and Stroke Prevention, CDC and lead author. "Increases in hospitalizations may reflect both improved recognition of pulmonary hypertension as well as an increase in treatment options."

Key findings from the study include:

  • Death rates from the disease rose more significantly for women at 2.5 % per year compared with a 0.9% per year increase for men.
  • Pulmonary hypertension death rates in those aged 85 and older increased more than 65% between 2001 and 2010.
  • Approximately 4 in 10 deaths associated with pulmonary hypertension occur among patients under 75 years old.
  • Hospitalization rates for women increased 52% while those of men increased 33% during the years studied. Women typically have a higher rate of connective tissue disease.
  • Women accounted for 61% of all pulmonary hypertension hospitalizations in 2001-02 and 63% in 2009-2010.
  • Congestive heart failure was the most commonly reported principal diagnosis at discharge, followed by other heart diseases (including pulmonary hypertension) and chronic and unspecified bronchitis.
  • Over the past decade, for black patients were approximately 40% higher than white patients.

"This study illustrates the importance of recognizing and diagnosing pulmonary hypertension so patients can receive proper treatment," says Richard S. Irwin, MD, Master FCCP, and editor in chief, CHEST. "It is essential information to aid clinicians in understanding the age, race, and gender differences in patients who are at risk for ."

The full study can be found in the online first section of CHEST.

Explore further: First guidelines for patients with pulmonary hypertension in sickle cell disease

Related Stories

First guidelines for patients with pulmonary hypertension in sickle cell disease

March 18, 2014
Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) physicians have helped create the first set of clinical guidelines for treating patients with pulmonary hypertension in sickle cell disease. Elizabeth ...

Pulmonary hypertension deaths and hospitalizations on the rise

October 22, 2012
New research indicates an increase in the number of US deaths and hospitalizations related to pulmonary hypertension. A research team from Howard University Hospital, Washington, DC, examined multiple cause of death mortality ...

ATS releases guidelines on the management of pulmonary hypertension of sickle cell disease

March 15, 2014
The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension.

Discovery sheds light on how changes in lungs can hurt the heart

November 11, 2013
A team of UW-Madison researchers has discovered important biomechanical changes in human arteries that could increase understanding of how pulmonary hypertension leads to heart failure.

Macitentan cuts morbidity, death in pulmonary arterial HTN

August 29, 2013
(HealthDay)—For patients with pulmonary arterial hypertension, the new dual endothelin-receptor antagonist macitentan is associated with reductions in morbidity and mortality, according to a study published in the Aug. ...

By zooming in on arteries, researcher gets to the root of pulmonary hypertension

February 27, 2014
You might think building muscle is a good thing, but that's often not so in the case of blood vessels in adults. In fact, excess smooth muscle is a root problem in many vascular diseases, as it causes arteries to constrict ...

Recommended for you

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.